The last journey, coming home before dying for migrant cancer patients: A case series.

IF 2 4区 医学 Q3 ONCOLOGY
Tumori Pub Date : 2025-01-30 DOI:10.1177/03008916251316175
Luca Zambelli, Alberto Gigliotti, Clara Bianchessi, Simeone Liguori, Sergio Defendi
{"title":"The last journey, coming home before dying for migrant cancer patients: A case series.","authors":"Luca Zambelli, Alberto Gigliotti, Clara Bianchessi, Simeone Liguori, Sergio Defendi","doi":"10.1177/03008916251316175","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Global migration has led to an increasing number of migrant patients receiving cancer diagnoses in foreign countries. These individuals often experience worse outcomes due to advanced disease at diagnosis and limited access to specialized care. When palliative care becomes the primary option, many express a wish to return to their home country for End-of-Life care. However, no guidelines or care pathways currently address this sensitive issue.</p><p><strong>Case presentation: </strong>This case series describes three migrant patients who wished to return to their home countries for End-of-Life care. The first case highlights the critical role of early communication, administrative challenges, and disparities in palliative care availability. The second case demonstrates that even highly disabled patients can undertake a final journey if clinically stable, provided appropriate accommodations and support are in place. Both cases followed a similar framework: identifying a palliative care provider in the home country and having a Mini-Team member accompany the patient. In contrast, the third case underscores the difficulty of fulfilling this wish when clinical deterioration progresses rapidly, preventing repatriation.</p><p><strong>Conclusion: </strong>Fulfilling the desire of migrant oncology patients to return to their home countries for End-of-Life care presents various challenges. These obstacles may arise from differences in national healthcare systems, administrative issues, and the patient's clinical condition. It is crucial for the Mini-Team to identify this wish as early as possible to secure appropriate arrangements in the patient's home country. Additionally, having a member of the Mini-Team accompany the patient during the journey can provide significant support.</p>","PeriodicalId":23349,"journal":{"name":"Tumori","volume":" ","pages":"3008916251316175"},"PeriodicalIF":2.0000,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tumori","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/03008916251316175","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Global migration has led to an increasing number of migrant patients receiving cancer diagnoses in foreign countries. These individuals often experience worse outcomes due to advanced disease at diagnosis and limited access to specialized care. When palliative care becomes the primary option, many express a wish to return to their home country for End-of-Life care. However, no guidelines or care pathways currently address this sensitive issue.

Case presentation: This case series describes three migrant patients who wished to return to their home countries for End-of-Life care. The first case highlights the critical role of early communication, administrative challenges, and disparities in palliative care availability. The second case demonstrates that even highly disabled patients can undertake a final journey if clinically stable, provided appropriate accommodations and support are in place. Both cases followed a similar framework: identifying a palliative care provider in the home country and having a Mini-Team member accompany the patient. In contrast, the third case underscores the difficulty of fulfilling this wish when clinical deterioration progresses rapidly, preventing repatriation.

Conclusion: Fulfilling the desire of migrant oncology patients to return to their home countries for End-of-Life care presents various challenges. These obstacles may arise from differences in national healthcare systems, administrative issues, and the patient's clinical condition. It is crucial for the Mini-Team to identify this wish as early as possible to secure appropriate arrangements in the patient's home country. Additionally, having a member of the Mini-Team accompany the patient during the journey can provide significant support.

背景:全球移民导致越来越多的移民患者在外国确诊癌症。由于确诊时已是晚期,且获得专业护理的机会有限,这些患者的预后往往较差。当姑息治疗成为主要选择时,许多人表示希望回国接受临终关怀。然而,目前还没有任何指南或护理路径来解决这一敏感问题:本系列病例描述了三位希望回国接受生命末期关怀的移民患者。第一个病例强调了早期沟通的关键作用、行政管理方面的挑战以及姑息关怀可用性方面的差异。第二个案例表明,即使是高度残疾的病人,如果病情稳定,只要有适当的便利和支持,也可以进行最后的旅程。这两个案例都采用了类似的框架:在本国确定姑息关怀提供者,并由一名迷你团队成员陪伴病人。相比之下,第三个案例则强调了在临床病情迅速恶化、无法遣返的情况下实现这一愿望的难度:结论:实现移民肿瘤患者回国接受临终关怀的愿望面临着各种挑战。这些障碍可能来自于各国医疗体系的差异、行政问题以及患者的临床状况。迷你小组必须尽早发现患者的这一愿望,以确保在患者本国做出适当的安排。此外,让迷你团队的一名成员在旅途中陪伴病人可以提供重要的支持。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Tumori
Tumori 医学-肿瘤学
CiteScore
3.50
自引率
0.00%
发文量
58
审稿时长
6 months
期刊介绍: Tumori Journal covers all aspects of cancer science and clinical practice with a strong focus on prevention, translational medicine and clinically relevant reports. We invite the publication of randomized trials and reports on large, consecutive patient series that investigate the real impact of new techniques, drugs and devices inday-to-day clinical practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信